Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	124.77	221.91	98.73
Graham Fair Price	41.42	59.34	41.96
PEG	-85.13	0.14	-0.92
Price/Book	23.07	1.32	1.07
Price/Cash Flow	38.46	-642.19	-1043.61
Prices/Earnings	-38.46	13.88	22.56
Price/Sales	45.77	63.27	43.40
Price/FCF	38.46	-642.19	-1043.61
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-8.86	0.90	0.99
Operating Margin	-48.48	0.38	0.74
ROA	100.00	0.01	< 0.005
ROE	0.01	0.02	100.00
ROIC	< 0.005	< 0.005	-56.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.02	-0.10	82.40
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.69	-0.56	-17.74
EPS QOQ	-0.24	1.01	313.94
FCF QOQ	0.90	-1.00	11.10
Revenue QOQ	0.10	-0.16	55.38
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-89.10
Days Sales Outstanding (DSO)	26.20	1252.22	4680.19
Inventory Turnover	487000.00	4468000.00	817.45
Debt/Capitalization	0.47	0.47	-0.90
Quick Ratio	0.91	3.42	277.54
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	81.14	81.14	< 0.005
Cash	7.69	7.69	< 0.005
Capex	0.00	0.00	0.00
Free Cash Flow	-0.08	-0.17	-100.00
Revenue	2.00	1.69	-15.57
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	4.75	4.75	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	42.39	83.20	96.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating